Edit |   |
---|---|
Antigenic Specificity | IL5RA, Human (Benralizumab biosimilar) |
Clone | Benralizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, FCM, IP, ELISA, Neut, FuncS, IF |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL5RA Recombinant Antibody. Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125). Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016. It was approved by the US Food and Drug Administration in November 2017 for the treatment of severe eosinophilic asthma. |
Immunogen | n/a |
Other Names | Anti-IL5RA Recombinant Antibody, Research Grade Benralizumab, Anti-Human IL5RA Recombinant Antibody, BIW-8405, KHK4563, MEDI-563, Antibody Drug Analogues, Monoclonal Antibody, YR1226, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1044511-01-4 |
Catalog # | YR1226 |
Price | please inquire |
Order / More Info | IL5RA, Human (Benralizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |